BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33161089)

  • 1. Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects.
    Rao JS; Zhang H; Kobetz E; Aldrich MC; Conway D
    Genomics; 2021 Jan; 113(1 Pt 2):1018-1028. PubMed ID: 33161089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
    Li C; Ke J; Liu J; Su J
    J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic analysis identifies factors driving racial disparity in prostate cancer.
    Rai R; Yadav SS; Pan H; Khan I; O'Connor J; Alshalalfa M; Davicioni E; Taioli E; Elemento O; Tewari AK; Yadav KK
    Cancer Rep (Hoboken); 2019 Apr; 2(2):e1153. PubMed ID: 32721098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.
    Neyaz MK; Kumar RS; Hussain S; Naqvi SH; Kohaar I; Thakur N; Kashyap V; Das BC; Husain SA; Bharadwaj M
    Biomarkers; 2008 Sep; 13(6):597-606. PubMed ID: 18608185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDH1 promoter methylation in patients with cervical carcinoma: a systematic meta-analysis with trial sequential analysis.
    Liu G
    Future Oncol; 2018 Jan; 14(1):51-63. PubMed ID: 29237293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China.
    Dong Y; Tan Q; Tao L; Pan X; Pang L; Liang W; Liu W; Zhang W; Li F; Jia W
    Int J Clin Exp Pathol; 2015; 8(2):1844-54. PubMed ID: 25973077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and construction of a prognostic risk model based on multi-RNA methylation regulators in cervical cancer.
    Yan X; Qu Y; Huang W; Zhang H; Zhu L; Zhang L
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3199-3208. PubMed ID: 36101016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer analysis of differential DNA methylation patterns.
    Shi M; Tsui SK; Wu H; Wei Y
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):154. PubMed ID: 33087120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel genetic and epigenetic regulators of different tissue types of cervical cancer.
    Chandra S; Sarkar S; Mandal P
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3179-3190. PubMed ID: 36184073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
    Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
    Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype prediction based on genome-wide DNA methylation data.
    Wilhelm T
    BMC Bioinformatics; 2014 Jun; 15():193. PubMed ID: 24934728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-epigenetic combination including quantitative methylation value of DKK3 augments survival prediction of the patient with cervical cancer.
    Kang WS; Cho SB; Park JS; Lee MY; Myung SC; Kim WY; Lee SH; Kim DH; Lee EJ
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):97-106. PubMed ID: 22961207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using epigenomics data to predict gene expression in lung cancer.
    Li J; Ching T; Huang S; Garmire LX
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S10. PubMed ID: 25861082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Linear Regression and Deep Learning Approach for Detecting Reliable Genetic Alterations in Cancer Using DNA Methylation and Gene Expression Data.
    Mallik S; Seth S; Bhadra T; Zhao Z
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
    Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
    Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
    Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
    Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The framework for population epigenetic study.
    Zhao L; Liu D; Xu J; Wang Z; Chen Y; Lei C; Li Y; Liu G; Jiang Y
    Brief Bioinform; 2018 Jan; 19(1):89-100. PubMed ID: 27760738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer.
    Bhat S; Kabekkodu SP; Noronha A; Satyamoorthy K
    Biochimie; 2016 Feb; 121():298-311. PubMed ID: 26743075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.
    Song MA; Brasky TM; Marian C; Weng DY; Taslim C; Dumitrescu RG; Llanos AA; Freudenheim JL; Shields PG
    Epigenetics; 2015; 10(12):1177-87. PubMed ID: 26680018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of transcription factors binding events based on epigenetic modifications in different human cells.
    Huang Y; Zhou D; Wang Y; Zhang X; Su M; Wang C; Sun Z; Jiang Q; Sun B; Zhang Y
    Epigenomics; 2020 Aug; 12(16):1443-1456. PubMed ID: 32921165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.